Strategic Acquisition SpectraWAVE is in the process of being acquired by Philips, signaling consolidation and potential access to broader distribution, integrative partnerships, and expanded budget for vascular imaging solutions.

Clinical leader With a focus on enhanced vascular imaging and AI-driven coronary physiology, there is a clear opportunity to position diagnostic and workflow optimization solutions to Philips’ hospital networks and affiliated imaging centers.

Leadership Growth Recent hires of a Chief Medical Officer and Chief Financial Officer indicate building executive depth; engage in enterprise-wide health-tech procurement conversations and multi-year roadmap discussions.

FDA Cleared Innovation HyperVue and wire-free physiology software add-ons demonstrate FDA-cleared, physician-friendly platforms; potential upsell to existing customers and integration into Philips’ cardiovascular imaging portfolio.

Strategic Partnerships Recent collaborations with CryoTherapeutics and ongoing AI-enabled imaging capabilities present opportunities for co-development, bundled offerings, and joint go-to-market strategies targeting interventional cardiology workflows.